Microbot Medical Inc. (NASDAQ:MBOT - Get Free Report)'s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $2.10 and traded as high as $2.56. Microbot Medical shares last traded at $2.48, with a volume of 1,134,539 shares changing hands.
Analyst Upgrades and Downgrades
Several equities research analysts have issued reports on the stock. HC Wainwright reissued a "buy" rating and issued a $9.00 price target on shares of Microbot Medical in a report on Thursday, April 10th. Wall Street Zen raised shares of Microbot Medical from a "sell" rating to a "hold" rating in a report on Saturday, June 14th.
Get Our Latest Report on Microbot Medical
Microbot Medical Stock Performance
The company's 50-day moving average is $2.56 and its 200-day moving average is $2.12. The firm has a market cap of $89.86 million, a price-to-earnings ratio of -3.80 and a beta of 1.13.
Microbot Medical (NASDAQ:MBOT - Get Free Report) last released its earnings results on Wednesday, May 21st. The biotechnology company reported ($0.08) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.07. On average, analysts predict that Microbot Medical Inc. will post -0.71 EPS for the current year.
Institutional Inflows and Outflows
A number of institutional investors have recently bought and sold shares of the business. Geode Capital Management LLC increased its position in shares of Microbot Medical by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 142,659 shares of the biotechnology company's stock valued at $160,000 after purchasing an additional 10,442 shares during the last quarter. Renaissance Technologies LLC bought a new stake in shares of Microbot Medical in the fourth quarter worth $118,000. Virtu Financial LLC bought a new stake in Microbot Medical during the first quarter valued at about $42,000. Goldman Sachs Group Inc. bought a new stake in Microbot Medical during the first quarter valued at about $57,000. Finally, U.S. Capital Wealth Advisors LLC bought a new position in shares of Microbot Medical in the second quarter worth about $25,000. Institutional investors own 16.30% of the company's stock.
About Microbot Medical
(
Get Free Report)
Microbot Medical Inc, a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces.
See Also
Before you consider Microbot Medical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Microbot Medical wasn't on the list.
While Microbot Medical currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access